Form 4 for IT Gartner
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-25 · accession 0001127602-21-024429 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-27 | 2021-08-25 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | M - OptEx | $80.06 | +21.7K | 56.0K | +63% | +$1.74M |
| D | 2021-08-27 | 2021-08-25 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | D - Sale to Iss | $307.19 | -5,649 | 50.4K | -10% | -$1.74M |
| D | 2021-08-27 | 2021-08-25 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | F - Tax | $307.19 | -6,306 | 44.1K | -13% | -$1.94M |
| D | 2021-08-27 | 2021-08-25 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | M - OptEx | $0.00 | -21.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | M | A | 21,675 | $80.06 | 56,044 | D | — | — | (F1) Represents shares acquired upon exercise of SARs. |
| 2 | Common | Common Stock | 2021-08-25 | D | D | 5,649 | $307.19 | 50,395 | D | — | — | (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| 3 | Common | Common Stock | 2021-08-25 | F | D | 6,306 | $307.19 | 44,089 | D | — | — | (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| 4 | Derivative | Stock Appreciation Rights | 2021-08-25 | M | D | 21,675 | $0.00 | 0 | D | $80.06 · 2017-02-08 to 2023-02-08 | 21,675 Common Stock | (F4) These SARs became excercisable in four substantially equal annual installments, commencing on February 8, 2017 and are fully exercisable. |